Optimization of hypothermosol using cultured cardiomyocytes and the fluorescent multiple endpoint assay
Van Buskirk, R.G.; Taylor, M.J.; Shen, R.; Tang, W.; Mathew, A.; Baust, J.G.
Cryobiology 32(6): 590-591
1995
ISSN/ISBN: 0011-2240
Accession: 032653252
PDF emailed within 1 workday: $29.90
Related References
Rhoads, L.S.; Cook, J.R.; Patrone, L.M.; Van Buskirk, R.G. 1993: A human epidermal model can be assayed employing a multiple fluorescent endpoint assay and the Cytofluor 2300 Journal of Toxicology Cutaneous and Ocular Toxicology 12(2): 87-108Rhoads, L.S.; Baust, J.G.; Van Buskirk, R.G. 1993: Structural integrity of a frozen human epidermal model can be examined with a fluorescent multiple endpoint assay Cryo Letters 14(2): 103-114
Rhoads, L.S.; Van Buskirk, R.G.; Baust, J.G. 1992: Cryopreservation of a human epidermal model Optimal protocols can be examined with a fluorescent multiple endpoint assay Cryobiology 29(6): 730-731
Piehl, M.; Gilotti, A.; Donovan, A.; DeGeorge, G.; Cerven, D. 2010: Novel cultured porcine corneal irritancy assay with reversibility endpoint Toxicology in Vitro: An International Journal Published in Association with Bibra 24(1): 231-239
Mathew, A.J.; Baust, J.G.; Van Buskirk, R.G. 1997: Optimization of hypothermosol for the hypothermic storage of cardiac cells - addition of EDTA In Vitro Toxicology 10(4): 407-415
Iatsyshina, S.B.; Portenko, S.A.; Astakhova, T.S.; Osina, N.A.; Rachina, S.A.; Garanina, S.B.; Zhukova, I.V.; Shishova, A.V.; Kondrat'eva, T.I.; Cherviakova, N.S.; Valova, T.V.; Ivanchik, N.V.; Krechikova, O.I.; Durasova, A.L.; Kulichenko, A.N.; Romanenko, V.V.; Tartakovskiĭ, I.S.; Maleev, V.V.; Shipulin, G.A. 2008: Development and use of the assay for Legionella pneumophila detection based on fluorescent real-time/endpoint polymerase-chain reaction Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 29-37
Mathur, A.; Hong, Y.; Kemp, B.K.; Barrientos, A.A.; Erusalimsky, J.D. 2000: Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes Cardiovascular Research 46(1): 126-138
Harris, R.P.; Helfand, M.; Woolf, S.H.; Lohr, K.N.; Mulrow, C.D.; Teutsch, S.M.; Atkins, D. 2020: REPRINT OF: Current Methods of the U.S. Preventive Services Task Force: A Review of the Process American Journal of Preventive Medicine 58(3): 316-331
Cook, Jr; Gabriels, J.P.trone, Lm; Rhoads, Ls; Van-Buskirk, Rg 1992: A human epidermal model that can be used in an automated multiple endpoint assay Alternatives to laboratory animals: ATLA 20(2): 313-323
Provinciali, M.; Di Stefano, G.; Fabris, N. 1992: Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (CFDA) and comparison with conventional 51CR release assay Journal of Immunological Methods 155(1): 19-24
Woods, E.; Berhow, M.; Mehta, P.; Wagner, E.D.; Plewa, M.J. 2001: Development of a multiple-endpoint assay to measure growth repression of tumor cells Environmental and Molecular Mutagenesis 37(Suppl 32): 80
Piccotti, J.R.; Knight, S.A.; Gillhouse, K.; Lagattuta, M.S.; Bleavins, M.R. 2006: Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison Journal of Applied Toxicology: Jat 26(4): 333-340
Christensen, M.L.M.; Braunstein, T.H.; Treiman, M. 2008: Fluorescence assay for mitochondrial permeability transition in cardiomyocytes cultured in a microtiter plate Analytical Biochemistry 378(1): 25-31
Zuppinger, C.; Schaub, M.C.; Eppenberger, H.M. 2000: Dynamics of early contact formation in cultured adult rat cardiomyocytes studied by N-cadherin fused to green fluorescent protein Journal of Molecular and Cellular Cardiology 32(4): 539-555
Nestler, H.; Groh, K.J.; Schönenberger, R.é; Behra, R.; Schirmer, K.; Eggen, R.I.L.; Suter, M.J.-F. 2012: Multiple-endpoint assay provides a detailed mechanistic view of responses to herbicide exposure in Chlamydomonas reinhardtii Aquatic Toxicology 110-111: 214-224